BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4667 related articles for article (PubMed ID: 3822871)

  • 1. Risk evaluation of UVB therapy for psoriasis: comparison of calculated risk for UVB therapy and observed risk in PUVA-treated patients.
    Slaper H; Schothorst AA; van der Leun JC
    Photodermatol; 1986 Oct; 3(5):271-83. PubMed ID: 3822871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
    Stern RS
    Blood Cells; 1992; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phototherapy of psoriasis - clinical aspects and risk evaluation.
    Larkö O
    Acta Derm Venereol Suppl (Stockh); 1982; 103():1-42. PubMed ID: 6964661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of skin cancer in the PUVA-48 cooperative study.
    Forman AB; Roenigk HH; Caro WA; Magid ML
    Arch Dermatol; 1989 Apr; 125(4):515-9. PubMed ID: 2649011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
    Hearn RM; Kerr AC; Rahim KF; Ferguson J; Dawe RS
    Br J Dermatol; 2008 Sep; 159(4):931-5. PubMed ID: 18834483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UVB doses in maintenance psoriasis phototherapy versus solar UVB exposure.
    Schothorst AA; Slaper H; Schouten R; Suurmond D
    Photodermatol; 1985 Aug; 2(4):213-20. PubMed ID: 4059077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin carcinomas and treatment with photochemotherapy (PUVA).
    Lindskov R
    Acta Derm Venereol; 1983; 63(3):223-6. PubMed ID: 6192635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TT; Hawk JL
    Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
    Stern RS;
    J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions.
    Trott J; Gerber W; Hammes S; Ockenfels HM
    Eur J Dermatol; 2008; 18(1):55-60. PubMed ID: 18086590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
    Lim JL; Stern RS
    J Invest Dermatol; 2005 Mar; 124(3):505-13. PubMed ID: 15737190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy of local narrowband ultraviolet B (NB-UVB) phototherapy versus psoralen plus ultraviolet A (PUVA) paint for palmoplantar psoriasis.
    Sezer E; Erbil AH; Kurumlu Z; Taştan HB; Etikan I
    J Dermatol; 2007 Jul; 34(7):435-40. PubMed ID: 17584319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic stimulation during ultraviolet therapy in man does not result in immunological tolerance.
    Friedmann PS; White SI; Parker S; Moss C; Matthews JN
    Clin Exp Immunol; 1989 Apr; 76(1):68-72. PubMed ID: 2736800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of psoralen - UVA photochemotherapy versus narrow band UVB phototherapy in the treatment of psoriasis.
    Tahir R; Mujtaba G
    J Coll Physicians Surg Pak; 2004 Oct; 14(10):593-5. PubMed ID: 15456547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepant levels of vascular endothelial growth factor in psoriasis patients treated with PUVA, Re-PUVA and narrow-band UVB.
    Akman A; Dicle O; Yilmaz F; Coskun M; Yilmaz E
    Photodermatol Photoimmunol Photomed; 2008 Jun; 24(3):123-7. PubMed ID: 18477130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis.
    Stern RS; Thibodeau LA; Kleinerman RA; Parrish JA; Fitzpatrick TB
    N Engl J Med; 1979 Apr; 300(15):809-13. PubMed ID: 423919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Audit of the use of psoralen photochemotherapy (PUVA) and narrowband UVB phototherapy in the treatment of psoriasis.
    Yones SS; Palmer RA; Kuno Y; Hawk JL
    J Dermatolog Treat; 2005 Apr; 16(2):108-12. PubMed ID: 16019625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study.
    Stern RS
    N Engl J Med; 1990 Apr; 322(16):1093-7. PubMed ID: 2320078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
    Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
    Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoralen plus UVA vs. UVB-311 nm for the treatment of lichen planus.
    Wackernagel A; Legat FJ; Hofer A; Quehenberger F; Kerl H; Wolf P
    Photodermatol Photoimmunol Photomed; 2007 Feb; 23(1):15-9. PubMed ID: 17254030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 234.